pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,989 catalysts · 5,347 phase readout · 2,296 8k filing · 343 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 23 catalysts2026-08-04: 13 catalysts2026-08-05: 18 catalysts2026-08-06: 11 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 1 catalyst2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,296
  • pdufa343
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Week of Jul 27, 2026

19
›Jul 31, 20268k filing4d ago$NBIX — NEUROCRINE BIOSCIENCES INC (NBIX) — 8-K filing

Items: 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d agoSilexion Therapeutics Corp (SLXN, SLXNW) — 8-K filing

Items: 5.02

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$AMGN — AMGEN INC (AMGN) — 8-K filing

Items: 1.05

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$CNTX — Context Therapeutics Inc. (CNTX) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$PDSB — PDS Biotechnology Corp (PDSB) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$AMRX — Amneal Pharmaceuticals, Inc. (AMRX) — 8-K filing

Items: 5.07

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$TRAW — Traws Pharma, Inc. (TRAW) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$EMBC — Embecta Corp. (EMBC) — 8-K filing

Items: 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d agobioAffinity Technologies, Inc. (BIAF, BIAFW) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d agoCalidi Biotherapeutics, Inc. (CLDI, CLDWW) — 8-K filing

Items: 3.03, 5.03, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$MIRA — MIRA PHARMACEUTICALS, INC. (MIRA) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$ATYR — aTYR PHARMA INC (ATYR) — 8-K filing

Items: 1.02, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d agoProfusa, Inc. (PFSA, NVACW) — 8-K filing

Items: 1.01, 3.02, 5.03, 7.01, 8.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$QNCX — Quince Therapeutics, Inc. (QNCX) — 8-K filing

Items: 5.02

full page →edgar 8k ↗
›Jul 31, 20268k filing4d agoGalera Therapeutics, Inc. (GRTX, GRTXD) — 8-K filing

Items: 3.02, 7.01, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$NWBO — NORTHWEST BIOTHERAPEUTICS INC (NWBO) — 8-K filing

Items: 1.01, 2.03

full page →edgar 8k ↗
›Jul 31, 20268k filing4d agoHumacyte, Inc. (HUMA, HUMAW) — 8-K filing

Items: 3.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d agoCDT Equity Inc. (CDT, CDTTW) — 8-K filing

Items: 1.01, 3.02, 9.01

full page →edgar 8k ↗
›Jul 31, 20268k filing4d ago$VTAK — Catheter Precision, Inc. (VTAK) — 8-K filing

Items: 3.02, 3.03, 5.03, 9.01

full page →edgar 8k ↗

Week of Aug 3, 2026

19
›Aug 3, 20268k filing1d ago$PTN — PALATIN TECHNOLOGIES INC (PTN) — 8-K filing

Items: 5.07, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$KRYS — Krystal Biotech, Inc. (KRYS) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$COCP — Cocrystal Pharma, Inc. (COCP) — 8-K filing

Items: 1.01, 3.02, 7.01, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$TNXP — Tonix Pharmaceuticals Holding Corp. (TNXP) — 8-K filing

Items: 7.01, 8.01, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$TGTX — TG THERAPEUTICS, INC. (TGTX) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$GNPX — Genprex, Inc. (GNPX) — 8-K filing

Items: 8.01, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$SUPN — SUPERNUS PHARMACEUTICALS, INC. (SUPN) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$SPTX — Seaport Therapeutics, Inc. (SPTX) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$AUTL — Autolus Therapeutics plc (AUTL) — 8-K filing

Items: 1.01, 2.03, 3.02, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$INDV — Indivior Pharmaceuticals, Inc. (INDV) — 8-K filing

Items: 2.02, 7.01, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$INDV — Indivior Pharmaceuticals, Inc. (INDV) — 8-K filing

Items: 1.01, 7.01, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$GKOS — GLAUKOS Corp (GKOS) — 8-K filing

Items: 7.01, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$OCUL — OCULAR THERAPEUTIX, INC (OCUL) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$BTAI — BioXcel Therapeutics, Inc. (BTAI) — 8-K filing

Items: 1.01, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$SUPN — SUPERNUS PHARMACEUTICALS, INC. (SUPN) — 8-K filing

Items: 1.01, 5.02, 8.01, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$TWST — Twist Bioscience Corp (TWST) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$AUTL — Autolus Therapeutics plc (AUTL) — 8-K filing

Items: 7.01, 8.01, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d ago$DSGN — Design Therapeutics, Inc. (DSGN) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 3, 20268k filing1d agoROCKET PHARMACEUTICALS, INC. (RCKT, RCKTW) — 8-K filing

Items: 7.01, 9.01

full page →edgar 8k ↗

Week of Jan 4, 2027

1
›Jan 4, 2027pdufa153dPDUFA — 2027-01-04

action date of January 4, 2027

full page →pdufa extract ↗

Week of Jan 18, 2027

1
›Jan 21, 2027pdufa170dPDUFA — 2027-01-21Ultragenyx Pharmaceutical Inc.

action date of Jan. 21, 2027

full page →pdufa extract ↗

Date TBD

10
›TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

full page →dexamethasone LA →fda approvals ↗
›TBDapprovalTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →OXCARBAZEPINE →fda approvals ↗
›RECRUITINGphase readoutNCT06924671: GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain

Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT07542236: Hip and Ankle Mobility Rehabilitation for Soccer Players With Patellofemoral Pain

Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06941844: A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)Definium Therapeutics, Inc.

Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06466434: Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Unresectable Melanoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06806709: Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)

Sponsor: The University of Queensland. Phase: NA. Conditions: Blood Culture Contamination, Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT07178509: A Study of SCAD Using Stress Contrast EchocardiographyMayo Clinic

Sponsor: Mayo Clinic. Phase: . Conditions: Spontaneous Coronary Artery Dissection

full page →ctgov ↗
›COMPLETEDphase readoutNCT07403409: Scapular Repeated Contractions Facilitation Versus Hold-relax Techniques in Patients With Adhesive Capsulitis

Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of the Shoulder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06721663: Multisensory Environment Stimulation Therapy on Postural Control in Cerebral Palsy

Sponsor: October 6 University. Phase: NA. Conditions: Cerebral Palsy

full page →ctgov ↗
← prev
page 53 of 160
next →
$RARE24.91-4.34%
$ABBV250.94-2.51%
$DFTX
$NVS156.15-1.45%